Peripherally Inserted Central Catheters are Witnessing Massive Adoption In Numerous Medical Procedures Including Chemotherapy

Peripherally Inserted Central Catheters


 Peripherally inserted peripheral catheters (PIIC) are used in modern medical practice, particularly among critically ill patients suffering from a variety of illnesses or conditions that could potentially be life-threatening. PICCs are typically used for a variety of indications, such as total parenteral nutrition, difficult venous distribution, difficult central venous pressure, and sometimes central venous monitoring. There are several options available to a doctor when deciding which catheter is best suited to the patient.

Venapro is a medical device designed to allow a physician to inject a controlled amount of medicine into a specific site. The procedure is performed under general anesthesia and it usually takes about fifteen minutes. During the procedure, a thin hollow needle called a picc line is inserted into one or more veins near the surface of the patient's body. When a vein is blocked, the pink line is guided through the blocked vein and injects the drug. Furthermore, In Situ Keratotomy involves the surgical removal of a specific vessel, or vena cava, with the use of a tiny cannula. Following the removal of the vena cava, a scar is created in the skin. This scar, called a stroma, is closed by sutures.

A small quantity of concentrated anesthesia is often added to the piccs for easier removal in the post-operative stage of chemotherapy, followed by rapid recovery at home. In venous access treatment, an artificial vein is constructed within the thigh or armpit using sterile medical catheters and IVC tubing. A tiny pump is inserted into the venous access hole. Once completed, a plastic ring is placed on the ring, trapping blood inside and preventing oxygen from reaching the tumor. A disposable needle is then inserted into the hole and the catheter is removed through the skin. C.R. Bard and Medikit are leader providers of peripherally inserted central catheters in Japan. Recently, B Braun launched Introcan Safety Deep Access IV catheters to boost its peripheral intravenous PIV access.  

Comments